CMS Energy Corp. (NYSE: CMS): KeyBanc Capital Markets raised its Sector Weight rating to Overweight with a $67 price target. That compares with the $65.95 consensus target and Monday’s close at $61.45.
Consolidated Edison Inc. (NYSE: ED): KeyBanc Capital Markets downgraded the utility to Underweight from Sector Weight, and it has a $66 price target. The consensus target is $75.79. The shares closed at $73.77 on Monday.
Cytokinetics Inc. (NASDAQ: CYTK): Goldman Sachs reiterated its Neutral rating and has a price target of $26. The posted consensus target is up at $32.64. The stock ended trading Monday at $27, which was up a stunning 40% on the day after the company posted positive results from a study of its investigational drug for hereditary heart disease.
Ford Motor Co. (NYSE: F): Zacks named this as its Bull of the Day stock. The analyst ponders whether this leading automaker finally has broken through the malaise. The stock most recently closed at $13.28 and has a consensus price target of $14.98.
Gatos Silver Inc. (NASDAQ: GATO): RBC Capital Markets not only upgraded the mining company’s stock to Outperform from Sector Perform but also lifted the price target to $18 from $15. The consensus target is $17.88. The shares ended trading on Monday at $12.70.
International Business Machines Corp. (NYSE: IBM): Societe Generale upgraded the venerable technology giant to Hold from Sell, and it also raised the price target to $140 from $121. The consensus target is $144.12. The shares were last seen on Monday at $137.92.
Incyte Corp. (NASDAQ: INCY): Benchmark raised its Hold rating to Buy with an $89 price target. The consensus price objective is up at $106.14. The shares closed on Monday at $77.56 apiece.
Inter Parfums Inc. (NASDAQ: IPAR): D.A. Davidson’s upgrade to Buy from Neutral included a price target boost to $90 from $80. The posted consensus target is $78.25. Monday’s last trade hit the tape at $67.55, and shares were almost 3% higher in premarket trading.
Krystal Biotech Inc. (NASDAQ: KRYS): The Goldman Sachs upgrade to Buy from Neutral came with a price target hike to $90 from $73. The consensus price target is even higher at $100. The shares closed on Monday at $61.09, which was down almost 4% for the day.
LivaNova PLC (NASDAQ: LIVN): Needham upgraded the shares to Buy from Hold and has a $93 price target. The consensus price objective is $95.17. The stock was last seen at $76.02 on Monday.